Gary Albert

3.1k total citations
12 papers, 607 citations indexed

About

Gary Albert is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Gary Albert has authored 12 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Gary Albert's work include Immunotherapy and Immune Responses (4 papers), Respiratory viral infections research (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Gary Albert is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Respiratory viral infections research (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Gary Albert collaborates with scholars based in United States, Germany and Canada. Gary Albert's co-authors include Donald Woytowitz, Mohammed Al-Adhami, Donald Gravenor, Mark W. Rolfe, Jeffrey Cehelsky, Marie Budev, Jared Gollob, Allan R. Glanville, Martin R. Zamora and Atul Humar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Gary Albert

11 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Albert United States 8 171 171 167 131 126 12 607
Philippa Hillyer United States 14 283 1.7× 390 2.3× 191 1.1× 113 0.9× 136 1.1× 18 824
Jatinder K. Juss United Kingdom 11 126 0.7× 253 1.5× 123 0.7× 117 0.9× 57 0.5× 16 526
F M Hofman United States 10 145 0.8× 169 1.0× 88 0.5× 61 0.5× 129 1.0× 14 492
Ju Ee Seet Singapore 11 130 0.8× 133 0.8× 143 0.9× 70 0.5× 75 0.6× 32 501
Wolfgang Meyer Germany 15 265 1.5× 170 1.0× 52 0.3× 67 0.5× 55 0.4× 52 635
Dorothea Ogmore Tilley Ireland 7 102 0.6× 313 1.8× 119 0.7× 53 0.4× 52 0.4× 9 536
Andrea Duppenthaler Switzerland 12 362 2.1× 183 1.1× 87 0.5× 157 1.2× 138 1.1× 32 670
Suna Erkılıç Türkiye 17 141 0.8× 61 0.4× 103 0.6× 102 0.8× 83 0.7× 55 638
Carmen Martín Spain 19 153 0.9× 252 1.5× 106 0.6× 57 0.4× 50 0.4× 47 916
Víctor Llorenç Spain 21 168 1.0× 100 0.6× 128 0.8× 165 1.3× 45 0.4× 76 1.4k

Countries citing papers authored by Gary Albert

Since Specialization
Citations

This map shows the geographic impact of Gary Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Albert more than expected).

Fields of papers citing papers by Gary Albert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Albert. The network helps show where Gary Albert may publish in the future.

Co-authorship network of co-authors of Gary Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Albert. A scholar is included among the top collaborators of Gary Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Albert. Gary Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Formica, Neil, Raburn M. Mallory, Gary Albert, et al.. (2021). Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Medicine. 18(10). e1003769–e1003769. 64 indexed citations
2.
Khalil, Nasreen, H. Manganas, Christopher J. Ryerson, et al.. (2018). Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis. European Respiratory Journal. 53(3). 1800663–1800663. 84 indexed citations
3.
Shapiro, Amy D., Charles Nakar, Joseph M. Parker, et al.. (2018). Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency. Blood. 131(12). 1301–1310. 33 indexed citations
4.
Zamora, Martin R., Marie Budev, Mark W. Rolfe, et al.. (2010). RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine. 183(4). 531–538. 169 indexed citations
5.
Zamora, Martin R., Marie Budev, Mark W. Rolfe, et al.. (2010). 41: Results of a Randomized Phase 2 Trial of ALN-RSV01, an RNAi Therapeutic, Lung Transplant (LTX) Patients Infected with Respiratory Syncytial Virus (RSV). The Journal of Heart and Lung Transplantation. 29(2). S20–S20. 4 indexed citations
6.
Manegold, Christian, Donald Gravenor, Donald Woytowitz, et al.. (2008). Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(24). 3979–3986. 129 indexed citations
7.
Gravenor, Donald, Donald Woytowitz, J. Mezger, et al.. (2005). CPG 7909, a TLR9 agonist, added to first line taxane/platinum for advanced non-small cell lung cancer, a randomized, controlled phase II study. Journal of Clinical Oncology. 23(16_suppl). 7039–7039. 17 indexed citations
8.
9.
10.
Gravenor, Donald, et al.. (2004). A TLR9 CpG immunomodulator in combination with chemotherapy as treatment for advanced non-small cell lung cancer (NSCLS), a randomized, controlled phase II study. Journal of Clinical Oncology. 22(14_suppl). 7126–7126. 1 indexed citations
11.
Joncas, J. H., G. Geoffroy, B McLaughlin, et al.. (1974). Subacute sclerosing panencephalitis. Journal of the Neurological Sciences. 21(4). 381–390. 93 indexed citations
12.
Schulte, F. J., Gary Albert, & R. Michaelis. (1969). Brain and Behavioural Maturation in Newborn Infants of Diabetic Mothers1– Part III: Motor behaviour2. Neuropediatrics. 1(1). 44–55. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippa Hillyer Breakdown of academic impact, for papers by Jatinder K. Juss Breakdown of academic impact, for papers by F M Hofman Breakdown of academic impact, for papers by Ju Ee Seet Breakdown of academic impact, for papers by Wolfgang Meyer Breakdown of academic impact, for papers by Dorothea Ogmore Tilley Breakdown of academic impact, for papers by Andrea Duppenthaler Breakdown of academic impact, for papers by Suna Erkılıç Breakdown of academic impact, for papers by Carmen Martín Breakdown of academic impact, for papers by Víctor Llorenç
Rankless by CCL
2026